UBS Group’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.01M | Sell |
39,100
-20,500
| -34% | -$2.78M | ﹤0.01% | 3867 |
|
|
2025
Q4 | $6.77M | Buy |
59,600
+21,600
| +57% | +$2.63M | ﹤0.01% | 3714 |
|
|
2025
Q3 | $5.05M | Sell |
38,000
-14,000
| -27% | -$1.92M | ﹤0.01% | 4022 |
|
|
2025
Q2 | $7.41M | Sell |
52,000
-35,500
| -41% | -$5.03M | ﹤0.01% | 3443 |
|
|
2025
Q1 | $13.4M | Buy |
87,500
+76,500
| +695% | +$12M | ﹤0.01% | 2761 |
|
|
2024
Q4 | $1.65M | Buy |
+11,000
| New | +$1.72M | ﹤0.01% | 4917 |
|
|
2024
Q2 | – | Sell |
-78,500
| Closed | -$10.8M | – | 9638 |
|
|
2024
Q1 | $10.8M | Buy |
78,500
+28,500
| +57% | +$3.42M | ﹤0.01% | 2203 |
|
|
2023
Q4 | $5.24M | Sell |
50,000
-43,200
| -46% | -$3.99M | ﹤0.01% | 2742 |
|
|
2023
Q3 | $8.81M | Sell |
93,200
-128,400
| -58% | -$13.1M | ﹤0.01% | 2081 |
|
|
2023
Q2 | $22.3M | Sell |
221,600
-231,800
| -51% | -$21.5M | 0.01% | 1373 |
|
|
2023
Q1 | $36.8M | Sell |
453,400
-17,400
| -4% | -$1.39M | 0.01% | 959 |
|
|
2022
Q4 | $35.2M | Buy |
470,800
+404,900
| +614% | +$31.4M | 0.01% | 1027 |
|
|
2022
Q3 | $5.46M | Sell |
65,900
-20,600
| -24% | -$1.81M | ﹤0.01% | 2279 |
|
|
2022
Q2 | $6.92M | Buy |
86,500
+65,900
| +320% | +$6.67M | ﹤0.01% | 2097 |
|
|
2022
Q1 | $2.33M | Buy |
+20,600
| New | +$2.31M | ﹤0.01% | 3289 |
|
|
2019
Q4 | – | Sell |
-154,600
| Closed | -$8.82M | – | 8161 |
|
|
2019
Q3 | $8.82M | Buy |
+154,600
| New | +$8.98M | ﹤0.01% | 1865 |
|
|
2018
Q4 | – | Sell |
-129,900
| Closed | -$9.3M | – | 8084 |
|
|
2018
Q3 | $9.3M | Buy |
129,900
+120,200
| +1,239% | +$8.5M | ﹤0.01% | 1839 |
|
|
2018
Q2 | $674K | Buy |
+9,700
| New | +$648K | ﹤0.01% | 4092 |
|
|
2018
Q1 | – | Sell |
-16,200
| Closed | -$1.17M | – | 7887 |
|
|
2017
Q4 | $1.17M | Sell |
16,200
-63,800
| -80% | -$3.93M | ﹤0.01% | 3652 |
|
|
2017
Q3 | $4.75M | Buy |
80,000
+57,300
| +252% | +$3.45M | ﹤0.01% | 2261 |
|
|
2017
Q2 | $1.47M | Buy |
+22,700
| New | +$1.5M | ﹤0.01% | 3285 |
|
|
2016
Q3 | – | Sell |
-88,300
| Closed | -$6.83M | – | 7725 |
|
|
2016
Q2 | $6.83M | Buy |
+88,300
| New | +$6.67M | ﹤0.01% | 1685 |
|
|
2016
Q1 | – | Sell |
-2,300
| Closed | -$160K | – | 7737 |
|
|
2015
Q4 | $160K | Hold |
2,300
| – | – | ﹤0.01% | 4850 |
|
|
2015
Q3 | $166K | Hold |
2,300
| – | – | ﹤0.01% | 4788 |
|
|
2015
Q2 | $183K | Hold |
2,300
| – | – | ﹤0.01% | 4943 |
|
|
2015
Q1 | $187K | Sell |
2,300
-300
| -12% | -$23K | ﹤0.01% | 4941 |
|
|
2014
Q4 | $197K | Buy |
+2,600
| New | +$196K | ﹤0.01% | 5060 |
|
Other funds holding DVA
VCM
VPM
UBS Group's DVA Position: Q1 2026 in Review
UBS Group increased its DaVita (DVA) stake by 106% in Q1 2026, buying an estimated $45.3M and bringing the position to 650,548 shares worth $100M. The position accounts for 0.02% of the portfolio, ranked #1046.
UBS Group first reported a position in DVA in Q4 2014 and has held it in 46 quarters since. The position peaked at $113M in Q4 2024. 582 funds tracked by Wall St. Rank hold DVA as of Q1 2026.
- UBS Group held 650,548 shares of DaVita worth $100M as of Q1 2026.
- UBS Group bought 334,217 DaVita shares in Q1 2026, an estimated $45.3M.
- DaVita made up 0.02% of UBS Group's portfolio in Q1 2026, its #1046 holding.
- UBS Group first reported a position in DaVita in Q4 2014 and has held it in 46 quarters since.
- UBS Group's DaVita position peaked at $113M in Q4 2024.
- 582 funds tracked by Wall St. Rank held DaVita as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.